Ptc Therapeutics (PTCT) Net Margin (2012 - 2026)
Ptc Therapeutics (PTCT) recorded quarterly Net Margin of 1.03% in Q1 2026, up 99.88% quarter-over-quarter from 834.08% in Q4 2025, and down 7471.0% on a YoY basis from 0.01% in Q1 2025.
Ptc Therapeutics (PTCT) Net Margin (2012 - 2026) Analysis & Trends
Ptc Therapeutics' Net Margin history runs 15 years deep, the most recent figure standing at 1.03% for Q1 2026.
- In Q1 2026, Net Margin fell 7471.0% year-over-year to 1.03%; the TTM figure through Mar 2026 stood at 172.32% (down 20983.0% YoY), while the FY2025 annual figure was 32.12%, up 1291.0% from the prior year.
- Net Margin was 1.03% for Q1 2026 at Ptc Therapeutics, up from 834.08% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 73.68% in Q1 2025 to a low of 834.08% in Q4 2025.
- Historically, Net Margin has averaged 95.17% across 5 years, with a median of 52.47% in 2023.
- Biggest YoY gain for Net Margin was 11726 bps in 2025; the steepest drop was 80317 bps in 2025.
- A 5-year view of Net Margin shows it stood at 102.08% in 2022, then soared by 50 bps to 50.74% in 2023, then soared by 39 bps to 30.91% in 2024, then slumped by 2599 bps to 834.08% in 2025, then soared by 100 bps to 1.03% in 2026.
- The last three Net Margin figures came in at 1.03% (Q1 2026), 834.08% (Q4 2025), and 7.53% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.82% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 34.53% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ptc Therapeutics | 6.51 Bn | 4.61 Bn | 244.52 Mn | -1.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.03% |
| Dec 31, 2025 | -834.08% |
| Sep 30, 2025 | 7.53% |
| Jun 30, 2025 | -36.25% |
| Mar 31, 2025 | 73.68% |
| Dec 31, 2024 | -30.91% |
| Sep 30, 2024 | -54.20% |
| Mar 31, 2024 | -43.58% |
| Dec 31, 2023 | -50.74% |
| Sep 30, 2023 | -67.64% |
| Jun 30, 2023 | -93.02% |
| Mar 31, 2023 | -63.05% |
| Dec 31, 2022 | -102.08% |
| Sep 30, 2022 | -50.35% |
| Jun 30, 2022 | -91.88% |
| Mar 31, 2022 | -85.20% |
| Dec 31, 2021 | -86.71% |
| Sep 30, 2021 | -96.31% |
| Jun 30, 2021 | -101.45% |
| Mar 31, 2021 | -109.07% |